Viewing Study NCT01288469


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-01-01 @ 8:24 AM
Study NCT ID: NCT01288469
Status: COMPLETED
Last Update Posted: 2015-09-24
First Post: 2011-02-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-01
Start Date Type: None
Primary Completion Date: 2011-09
Primary Completion Date Type: ACTUAL
Completion Date: 2011-09
Completion Date Type: ACTUAL
First Submit Date: 2011-02-01
First Submit QC Date: None
Study First Post Date: 2011-02-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-08-21
Results First Submit QC Date: None
Results First Post Date: 2015-09-24
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2012-12-17
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2015-08-21
Last Update Post Date: 2015-09-24
Last Update Post Date Type: ESTIMATED